Dr. Lal PathLabs Limited Share Price
Equities
LALPATHLAB
INE600L01024
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,381.80 INR | -1.02% |
|
+0.10% | +31.19% |
| 12/08 | Nomura Adjusts Dr. Lal PathLabs' Price Target to INR3,720 From INR2,713, Keeps at Buy | MT |
| 08/08 | Dr. Lal PathLabs' Consolidated Net Profit Shows Growth in Fiscal Q1 | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Enjoy this offer
* See conditions on site
| Capitalization | 28TCr 335.83Cr | P/E ratio 2025 * |
65.8x | P/E ratio 2026 * | 55.8x |
|---|---|---|---|---|---|
| Enterprise value | 18TCr 215.7Cr | EV / Sales 2025 * |
10.8x | EV / Sales 2026 * | 9.51x |
| Free-Float |
43.95% | Yield 2025 * |
0.65% | Yield 2026 * | 0.75% |
More valuation ratios
* Estimated data
More news
Last Transcript: Dr. Lal PathLabs Limited
More recommendations
| 1 day | -1.02% | ||
| 1 week | +0.10% | ||
| Current month | -1.04% | ||
| 1 month | +3.84% | ||
| 3 months | +21.75% | ||
| 6 months | +68.09% | ||
| Current year | +31.19% |
1 week
3 351.05
3 436.10
1 month
3 210.203 459.40
Current year
1 943.703 459.40
1 year
1 943.703 459.40
3 years
1 762.054 245.50
5 years
1 179.554 245.50
10 years
696.504 245.50
| Director | Title | Age | Since |
|---|---|---|---|
Shankha Banerjee
CEO | Chief Executive Officer | - | 01/14/01 |
Ved Prakash Goel
DFI | Director of Finance/CFO | - | 01/06/01 |
| Chief Operating Officer | - | 01/22/01 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arvind Lal
CHM | Chairman | 74 | 14/95/14 |
Vandana Lal
CTO | Chief Tech/Sci/R&D Officer | 68 | 14/95/14 |
Rahul Sharma
BRD | Director/Board Member | 64 | 22/05/22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.10% | 6 M€ | +6.07% | - | |
| 0.01% | 4 M€ | -4.41% | - | |
| 0.01% | 99 M€ | +5.11% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -1.02% | +0.10% | +50.94% | -18.91% | 335.86Cr | ||
| +0.26% | -0.63% | -13.12% | -35.83% | 870.99Cr | ||
| +0.83% | +8.62% | +146.24% | +139.37% | 501.36Cr | ||
| -0.18% | -.--% | +25.68% | -45.49% | 269.51Cr | ||
| +1.23% | +2.24% | +19.53% | -68.19% | 210.18Cr | ||
| -1.39% | -0.50% | -50.95% | -71.66% | 180.8Cr | ||
| +4.51% | -0.36% | +13.79% | -27.46% | 163.89Cr | ||
| +0.06% | +1.79% | +51.65% | -29.14% | 133.02Cr | ||
| -2.11% | -0.15% | +93.31% | - | 112.31Cr | ||
| +1.29% | +0.64% | -4.27% | -56.15% | 108.64Cr | ||
| Average | +0.35% | +0.89% | +33.28% | -23.72% | 288.66Cr | |
| Weighted average by Cap. | +0.31% | +1.11% | +34.63% | -7.83% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.5TCr 30Cr | 2.81TCr 34Cr |
| Net income | 430.24Cr 5.13Cr | 507.51Cr 6.05Cr |
| Net Debt | -1.07TCr -13Cr | -1.45TCr -17Cr |
More financial data
* Estimated data
Employees
4,099
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/24/13 | 3,381.80 ₹ | -1.02% | 231,455 |
| 12/24/12 | 3,416.80 ₹ | +0.61% | 185,449 |
| 11/24/11 | 3,396.15 ₹ | +0.54% | 74,231 |
| 10/24/10 | 3,377.80 ₹ | -0.03% | 123,772 |
| 09/24/09 | 3,378.70 ₹ | +0.01% | 107,431 |
Delayed Quote NSE India S.E., September 13, 2024 at 05:10 pm IST
More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
3,381.80INR
Average target price
3,134.09INR
Spread / Average Target
-7.32%
- Stock Market
- Equities
- LALPATHLAB Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition